Literature DB >> 18180007

Circulating fibrocytes: cellular basis for NSF.

Richard Bucala1.   

Abstract

Since the discovery of the circulating fibrocyte as a collagen-producing cell of the peripheral blood, the physiologic and pathologic role of this unique cell population has grown steadily. The present review summarizes the known biology of fibrocytes and discusses evidence for their role in the pathogenesis of nephrogenic systemic fibrosis. Possible mechanisms by which gadolinium may influence the activation or trafficking properties of fibrocytes leading to tissue fibrosis are discussed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18180007     DOI： 10.1016/j.jacr.2007.08.016

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN： 1546-1440            Impact factor:   5.532


  36 in total

Review 1.  Potential role for bone marrow-derived fibrocytes in the orbital fibroblast heterogeneity associated with thyroid-associated ophthalmopathy.

Authors:  T J Smith
Journal:  Clin Exp Immunol       Date:  2010-08-19       Impact factor: 4.330

Review 2.  Anti-fibrosis therapy and diabetic nephropathy.

Authors:  Anil Karihaloo
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

Review 3.  The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis.

Authors:  Robert M Strieter; Ellen C Keeley; Marie D Burdick; Borna Mehrad
Journal:  Trans Am Clin Climatol Assoc       Date:  2009

Review 4.  Renal interstitial fibrosis: mechanisms and evaluation.

Authors:  Alton B Farris; Robert B Colvin
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

5.  Hyperphosphataemia sensitizes renally impaired rats to the profibrotic effects of gadodiamide.

Authors:  N Fretellier; Jm Idée; P Bruneval; S Guerret; F Daubiné; G Jestin; C Factor; N Poveda; A Dencausse; F Massicot; O Laprévote; C Mandet; N Bouzian; M Port; C Corot
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

6.  Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study.

Authors:  Barbara Ruaro; Stefano Soldano; Vanessa Smith; Sabrina Paolino; Paola Contini; Paola Montagna; Carmen Pizzorni; Andrea Casabella; Samuele Tardito; Alberto Sulli; Maurizio Cutolo
Journal:  Rheumatol Int       Date:  2019-05-06       Impact factor: 2.631

7.  Gadolinium-promoted cell cycle progression with enhanced S-phase entry via activation of both ERK and PI3K signaling pathways in NIH 3T3 cells.

Authors:  Li-Juan Fu; Jin-Xia Li; Xiao-Gai Yang; Kui Wang
Journal:  J Biol Inorg Chem       Date:  2008-10-25       Impact factor: 3.358

Review 8.  New insights into epithelial-mesenchymal transition in kidney fibrosis.

Authors:  Youhua Liu
Journal:  J Am Soc Nephrol       Date:  2009-12-17       Impact factor: 10.121

Review 9.  The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of fibrotic disorders.

Authors:  Ellen C Keeley; Borna Mehrad; Robert M Strieter
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

10.  Biphasic presence of fibrocytes in a porcine hypertrophic scar model.

Authors:  Taryn E Travis; Matthew J Mino; Lauren T Moffatt; Neil A Mauskar; Nicholas J Prindeze; Pejhman Ghassemi; Jessica C Ramella-Roman; Marion H Jordan; Jeffrey W Shupp
Journal:  J Burn Care Res       Date:  2015 May-Jun       Impact factor: 1.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.